Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT02205047 · COMPLETED

Trial details

NCT number: NCT02205047
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasm of Stomach Malignant Neoplasm of Cardio-esophageal Junction of Stomach Epidermal Growth Factor Receptor (EGFR) Protein Overexpression

Start date: 2015-07-15
Primary completion: 2022-12-22
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.